ELVN

Conviction 84HealthcareScan · Mon, Aug 10, 2026

Gravestone doji

ELVN$59.39-1.77%

ResistanceSupportVol 14Insider sell

Vol MA14 1.17M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Enliven Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.enliventherapeutics.com ↗

Price59.39

Change-1.77%

Gap-1.59%

Rel volume1.18×

Avg volume1.03M

Avg $ vol58.05M

SMA 2055.04

SMA 5048.71

SMA 20033.96

Price vs 50+21.94%

Price vs 200+74.91%

MA stackbullish

50/200 cross—

Supertrendup · 51.57

RSI (14)66

MACD hist0.36

MACD crossbull · 5d

Stoch %K / %D73 / 79

ADX (14)43

+DI / −DI25 / 8

RSI divergence—

MACD divergence—

ATR %+4.94%

ADR %5.24%

52w high61.11

52w low15.14

From 52w high-2.81%

Above 52w low+292.27%

New 52w highNo

SqueezeOff

Bollinger width23.94%

%B0.83

Donchian pos77.04%

Donchian high62.32

Donchian low49.56

AVWAP (52w high)60.09

vs AVWAP high-1.16%

AVWAP (52w low)39.10

vs AVWAP low+51.89%

OBV trendUp

Chaikin MF (20)0.13

Today vs 20d1.18×

Avg vol (14d)1.17M

Avg vol (20d)1.03M

Avg $ vol (20d)58.05M

Market cap—

RS 3m (vs SPY)+44.36%

RS 6m (vs SPY)+109.89%

RS line new highNo

Trend template8/8

Technical rank91.3

1 week+2.33%

1 month+16.25%

3 months+45.74%

6 months+101.87%

1 year+231.79%

YTD+282.18%

P/E-42.66

P/B4.94

P/S—

P/FCF-62.78

EPS-1.83

Div yield—

ROE-11.58%

ROA-11.39%

Debt/Eq—

Current64.07

EV/EBITDA-35.92

Gross margin—

Net margin—

Rev growth—

EPS growth-16.48%

Price target70.90

Target upside17.44%

Analyst ratingBuy

Institutional91.63%

Ent. value4.29B

Revenue—

Net income-32.48M

Gross profit—

Free cash flow-70.46M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out60.9M

Employees61

ListedFri, Feb 24, 2023

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction84 / 100

Pattern quality—

Tech rank91.3 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmGravestone doji

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ELVN

All disclosures →

No recent disclosed trades by Congress in ELVN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ELVN · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Kunkel Lori Anne Director · Common Stock · 2026-07-06	Sell	4.11K	$205K	2026-07-06	2026-07-08
Kunkel Lori Anne Director · Common Stock · 2026-07-06	Sell	5.89K	$299K	2026-07-06	2026-07-08
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17	Exercise	5K	$12K	2026-06-17	2026-06-22
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17	Sell	1.27K	$54K	2026-06-17	2026-06-22
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17	Sell	2.6K	$114K	2026-06-17	2026-06-22
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-06-17	Sell	1.13K	$51K	2026-06-17	2026-06-22
Collins Helen Louise CHIEF MEDICAL OFFICER · Stock Option (right to buy) · 2026-06-17	Exercise	5K	—	2026-06-17	2026-06-22
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-17	Exercise	6.02K	$15K	2026-06-17	2026-06-22
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-17	Sell	1.38K	$59K	2026-06-17	2026-06-22
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-17	Sell	3.4K	$149K	2026-06-17	2026-06-22

SEC filings

EDGAR filings in ELVN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.